Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

INNOVET COMPLETES ACQUISITION

Feb. 14, 1992

TOP-TIER STOCKS SHAKEN IN FALLOUT

Feb. 13, 1992

IDEC TO CONSOLIDATE LOCATIONS

Feb. 13, 1992

MEDICIS LICENSES HAIR LOSS DRUG

Feb. 13, 1992

GENETIC ENGINEERING ACQUIRED

Feb. 13, 1992

ERI ACQUIRES MICROBIOLOGICAL DEVELOPER

Feb. 13, 1992

GENZYME ANSWERS HIGH PRICE ALLEGATION

Feb. 13, 1992

BST BAN EXTENDED IN EUROPE

Feb. 12, 1992

BIOTECH PERSPECTIVE ON DRUG SETBACKS

Feb. 12, 1992

TELIOS FILES FOR 3 MILLION-SHARE IPO

Feb. 12, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.